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Abstract
Brucella spp. are facultative intracellular pathogens that have the ability to survive and multiply in
professional and non-professional phagocytes, and cause abortion in domestic animals and undulant
fever in humans. Several species are recognized within the genus Brucella and this classification is
mainly based on the difference in pathogenicity and in host preference. Brucella strains may occur
as either smooth or rough, expressing smooth LPS (S-LPS) or rough LPS (R-LPS) as major surface
antigen. This bacterium possesses an unconventional non-endotoxic lipopolysaccharide that
confers resistance to anti-microbial attacks and modulates the host immune response. The strains
that are pathogenic for humans (B. abortus, B. suis, B. melitensis) carry a smooth LPS involved in the
virulence of these bacteria. The LPS O-chain protects the bacteria from cellular cationic peptides,
oxygen metabolites and complement-mediated lysis and it is a key molecule for Brucella survival and
replication in the host. Here, we review i) Brucella LPS structure; ii) Brucella genome, iii) genes
involved in LPS biosynthesis; iv) the interaction between LPS and innate immunity.
Background
Brucellae  are Gram-negative cocccobacilli, facultative
intracellular bacterial pathogens of both humans and ani-
mals. The bacteria penetrate the mucosa of the nasal, oral,
or pharyngeal cavities and are phagocytized by host mac-
rophages, where survival and replication occurs. Brucello-
sis is a zoonotic disease that is difficult to diagnose and
treat that causes heavy economic losses and human suffer-
ing, characterized by undulant fever that, if untreated, can
develop into a chronic infection with symptoms persist-
ing for several months. Chronic infections may result in
infection of secondary tissues, including heart and brain.
Symptoms may also recur years after the original infec-
tion. The pathological manifestations of brucellosis are
diverse and include arthritis, endocarditis, and meningitis
in humans, while animal brucellosis is characterized by
spontaneous abortion [1]. Six species are recognized
within the genus Brucella: B. abortus, B. melitensis, B. suis,
B. ovis,  B. canis, and B. neotomae. This classification is
mainly based on the difference in pathogenicity and in
host preference [2]. The main pathogenic species world-
wide are B. abortus, responsible for bovine brucellosis; B.
melitensis, the main etiologic agent of ovine and caprine
brucellosis, a disease that causes abortion in ewes and
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goats resulting in huge economic losses, particularly in
Mediterranean countries and B. suis responsible for swine
brucellosis. B. abortus infection is acquired by humans
through contact with infected livestock and consumption
of unpasteurized dairy products. B. ovis and B. canis are
responsible for ram epididymitis and canine brucellosis,
respectively [3]. For B. neotomae only strains isolated from
desert rats have been reported. Brucella strains have also
been isolated from a great variety of wildlife species such
as bison, elk, feral swine, foxes, hares, African Buffalo,
reindeer, and caribou [4]. Recently, two new species have
been proposed to be added to this genus, Brucella cetaceae
and Brucella pinnipediae isolated from marine mammals,
cetaceans and pinnipeds, respectively [5,6]. Distinction
between species and biovars is currently performed by dif-
ferential tests based on phenotypic characterization of
lipopolysaccharide antigens, phage typing, dye sensitivity,
CO2 requirement, H2S production, and metabolic proper-
ties [7].
Additionally, Brucella can be used as a biological weapon
since transmission through a spray is possible, as has been
reported with human contamination during abortion of
infected animals or bacterial spraying in laboratories [8].
The bacteria is highly contagious and it is suggested that
10 to 100 bacteria would be sufficient to produce a con-
taminating spray for humans. Several countries have been
suspected of studying the agent as a biological weapon,
but to date, no use of Brucella in a bioterrorist attack has
been reported.
In this article, we review the importance of the lipopoly-
saccharide in Brucella virulence, discussing the LPS chem-
ical composition, the Brucella genome, the genes involved
Schematic structure of lipopolysaccharide (LPS) from Brucella spp Figure 1
Schematic structure of lipopolysaccharide (LPS) from Brucella spp.
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in LPS biosynthesis, and the interaction between LPS and
innate immunity.
Chemical composition of lipopolysaccharide 
from different Brucella strains
Several studies on virulence factors were directed at the
main components of the outer membrane. The outer
membrane contains the lipopolysacharide (LPS) that is
the Brucella major virulence factor. Lipopolysaccharide is
vital to both the structural and functional integrity of the
Gram-negative bacterial outer membrane. Ubiquitously
expressed by all Gram-negative bacteria, and containing
several well-conserved domains, LPS also serves as one of
the primary targets of the innate arm of the mammalian
immune system. Brucella possesses a peculiar non-classi-
cal LPS as compared with classical LPS from enterobacte-
ria such as Escherichia coli [9]. The LPS was identified as a
major virulence determinant of Brucella recognized for its
role in virulence when naturally occurring isolates lacking
LPS showed reduced survival. LPS has three domains:
lipid A, the core oligosaccharide, and the O-antigen or O-
side chain (Figure 1). The O-polysaccharide of smooth-
type Brucella LPS (S-LPS) is an unbranched homopolymer
of 1,2-linked4,6-dideoxy-4-formamido-α-D-man-
nopyranosyl usually with an average chain length of 96 to
100 glycosyl subunits [10]. The O-polysaccharide is
linked to a core oligosaccharide composed of mannose,
glucose, 2-amino-2,6-dideoxy-D-glucose (quinov-
osamine), 2-amino-2-deoxy-D-glucose (glucosamine), 3-
deoxy-D-manno-2-octulosonic acid (KDO) and unidenti-
fied sugars. The lipid A, linked to the core oligosaccharide,
contains 2,3-diamino-2,3-dideoxy-D-glucose
(diaminoglucose) as backbone, amide and ester-linked
long chain saturated (C16:0 to C18:0) and hydroxylated (3-
OH-C12:0 to 29-OH-C30:0) fatty acids [11]. The hydropho-
bic lipid A region constitutes mostly the outer coating of
the outer membrane and is responsible for many of the
endotoxic properties attributed to LPS [12]. Thermotropic
phase behaviour [13] and immunochemical analysis [14]
of B. abortus and B. melitensis lipid A suggest a disaccharide
backbone molecule linked in a β1–6 configuration. Eth-
anolamine, neutral sugars and ester-linked acyl-oxyacyl
fatty acids are not found, and phosphate is absent or
present in reduced quantities [11]. Brucella lipid A con-
tains strongly bound outer membrane protein fragments
that are not removed by conventional procedures used to
release the lipid-A-associated protein of enterobacterial
LPS [11,14]. The heterogeneity of enterobacterial LPS is
well known to be related to the length of its O-polysaccha-
ride and different chemical substitutions in the core oli-
gosaccharide and lipid A [15]. In enterobacterial lipid A,
the degree of heterogeneity depends upon the different
combinations in which amide and ester-linked fatty acids,
phosphate, neutral sugars, ethanolamine and different
types of backbone amino sugars occur in the molecule
[16]. In Brucellae lipid A, the degree of heterogeneity may
depend mainly on the various fatty acid substitutions. The
absence of backbone constituents (other than lipids) and
ester-linked acyl-oxyacyl residues in Brucella lipid A might
account for the restricted number of variants as compared
to enterobacterial lipid A. Determination of the intrinsic
heterogeneity in Brucella LPS is important to explain in a
more realistic perspective its chemical nature and biolog-
ical behavior. For practical purposes, this is significant,
since LPS is the most relevant antigen during infection
and vaccination. In addition, LPS and LPS-related mole-
cules are extensively used in immunological studies and
in the diagnosis of brucellosis [17].
Brucella genomes
Recently, the genome sequences of the B. melitensis, B. suis
and B. abortus became available [18-20]. The genomes of
B. suis,  B. melitensis, and B. abortus are very similar in
sequence, organization, and structure. Few fragments are
unique among the genomes [20]. Although many aspects
of its biology remain to be understood, the sequencing
and annotation of its genome paved the way for a highly
comprehensive and rapid analysis of its proteome. Com-
parative genomics provide insights into aspects of Brucella
virulence that were only suspected before. The era of post-
genomic technology offers new and exciting opportuni-
ties to understand the complete biology of different Bru-
cella species. At the proteome level, extensive metabolic
differences were found between the B. melitensis reference
strain 16 M and its vaccine strain Rev 1. Similarly, labora-
tory grown B. melitensis can be distinguished from B. abor-
tus  by just looking at their proteome [21]. Using the
complete genome sequence of Brucella melitensis, Dricot et
al. [22] generated a database of protein-coding ORFs and
constructed an ORFeome library of 3091 Gateway entry
clones, each containing a defined ORF. This first version
of the Brucella  ORF (Version 1.1) provides the coding
sequences in a user-friendly format amenable to high-
throughput functional genomic and proteomic experi-
ments, as the ORFs are conveniently transferable from the
entry clones to various expression vectors by recombina-
tional cloning. The cloning of the Brucella ORFeome v.1.1
should help to provide a better understanding of the
molecular mechanisms of virulence, including the identi-
fication of bacterial protein-protein interactions, but also
interactions between bacterial effectors and their host tar-
gets.
The genome of B. melitensis strain 16 M contain 3,294,935
bp distributed over two circular chromosomes of
2,117,144 bp and 1,177,787 bp encoding 3,197 open
reading frames (ORFs). The origins of replication of the
two chromosomes are similar to those of other proteobac-
teria. Housekeeping genes, including those involved in
DNA replication, transcription, translation, core metabo-Microbial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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lism, and cell wall biosynthesis, are distributed on both
chromosomes [21]. Screens for transpositional mutants
attenuated in infection models yielded 184 mutants, sug-
gesting that these genes have a function in the infection
process [23]. The B. suis 1330 genome consists of two cir-
cular chromosomes of 2,107,792 bp and 1,207,381 bp
[19]. A total of 2,185 and 1,203 ORFs were identified on
chromosomes I and II, respectively. Comparison of the B.
suis genome with that of the B. melitensis genome revealed
extensive similarity and gene synteny [21]. The majority
(>90%) of B. suis and B. melitensis genes share 98–100%
identity at the nucleotide level. The more variable genes
(<95% identity) consist primarily of hypothetical genes,
as well as a UreE urease component, and probable surface-
exposed genes such as outer membrane proteins, mem-
brane transporters, a putative invasin, and ShdA-like
adhesins. These more variable genes may significantly
contribute to the differences in pathogenicity or host pref-
erence between these two organisms. The high degree of
similarity between the B. suis and B. melitensis genomes at
both the gene and nucleotide level is consistent with the
proposition that Brucella  species should be grouped as
biovars of a single species.
The genome of B. abortus biovar 1 (Strain 9-941) have 3.3
Mb and is composed of two circular chromosomes of
2,124,242 (Chr I) and 1,162,780 bp (Chr II) [20]. The
chromosome sequences of B. abortus 9-941 were assigned
the same strand orientation and origin as those of B. suis.
The B. abortus genome contains 3,296 ORFs annotated as
genes, 2,158 on Chr I and 1,138 an Chr II. This is similar
to the annotated ORF counts for B. suis (3,388) and B.
melitensis (3,197). The genome of B. abortus shared more
fragments with B. suis and B. melitensis than B. suis and B.
melitensis did with each other. B. abortus shared more frag-
ments with B. melitensis than B. suis. Two fragments shared
by B. suis and B. melitensis were not found in B. abortus. A
2,774-bp fragment encoding a probable surface protein
and two partial ORFs with homology to the insertion
sequences IS711 and ISBm1 is missing from B. abortus. The
second fragment is a 25-kb sequence that may be involved
in polysaccharide synthesis and was predicted by Vizcaino
et al. [24] to potentially affect phenotypes of brucellae,
such as host preference.
Genes involved in LPS biosynthesis
The majority of studied genes and their products involved
in Brucella LPS biosynthesis are those related to O-chain
synthesis (Table 1). The large number of attenuated
mutants with a structural defect in their lipopolysaccha-
ride (LPS) confirms the importance of this molecule in
Brucella virulence. In spite of the importance of LPS in the
Brucella life cycle, very little is known about the metabolic
pathways and enzymes required to synthesize it. Certain
strains carry mutations in the genes involved in O-chain
biosynthesis and attachment and are termed 'rough
mutants'(R) strains to differentiate them from the wild-
type 'smooth' (S) strains that express O-chain-bearing
LPS. Historically, the search for rough mutants was per-
formed in two ways: by a spontaneous phenomenon
known as phase variation, in which rough variants appear
in culture by a mechanism not well understood [7], or by
successive passages in different culture media with search-
ing for spontaneously rough phenotypes. These proce-
dures gave a high number of rough mutants. All of them
are avirulent in animal models, but in most cases the
parental strain is not available. B. abortus, B. melitensis, and
B. suis strains may occur as either smooth or rough,
expressing smooth LPS (S-LPS) or rough LPS (R-LPS) as
major surface antigen, while B. ovis and B. canis are two
naturally R species, expressing R-LPS as major surface anti-
gen. Generally these mutants are less virulent than the
wild type, with the exception of those of Brucella ovis and
B. canis, which are rough but virulent. It is accepted that
rough mutants are more sensitive to lysis mediated by
complement, and probably this is the main reason why
most rough variants have an avirulent phenotype in ani-
mal models. To date the question about the capacity of
rough mutants to replicate intracellularly is not solved.
Some authors have reported that smooth LPS is essential
for intracellular survival [25], for example, the vaccine
strain RB51 exhibits loss of virulence and cannot replicate
within macrophages [26]. On the other hand, there are
some reports in which genetically characterized rough
mutants did not loose the capacity to replicate intracellu-
larly despite the total absence of the O-antigen [27]B.
abortus strain RB51 is a stable rough (R) mutant derived
from the standard smooth (S) virulent strain 2308. This
rough mutant strain that does not contain the O-antigen
(O polysaccharide chain of the smooth LPS) is attenuated
in its virulence compared to their smooth virulent paren-
tal strain [27]. Even though the Brucella RB51 rough strain
has been widely used as a live vaccine, it induces lower
protection compared to the smooth vaccine strain S19
[28]. At similar concentrations, the Brucella vaccine strain
Table 1: Genes encoding O-antigen biosynthesis in Brucella spp.
Gene Product
Gmd GDP-mannose dehydratase
Per Perosamine synthetase
Pgm Phosphoglucomutase
Pmm Phosphomannomutase
ManB Mannose isomerase
ManC Mannose guanylyltransferase
Wzm O-antigen export permease
Wzt ATP-binding protein
WbkB no similarity to known genes
WbkC Methionyl tRNA formyltransferase
WbkA N-formyl-perosaminyltransferaseMicrobial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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S19 induces higher protection than the R vaccine strain
(RB51). The lack of protective antibodies to the O-side
chain of the LPS in animals immunized with B. abortus
RB51 may explain in part why the R strain induces lower
protection against infection [29]. A major problem in ani-
mal vaccination against brucellosis with currently used
live attenuated smooth Brucella strains, such as B. meliten-
sis strain Rev.1 for sheep and goats and B. abortus strain
S19 for cattle, is the fact that vaccinated animals cannot be
clearly differentiated from infected animals by the current
serological tests. Further, these strains may induce abor-
tions when used in pregnant animals and are virulent for
humans. These tests are indeed based on detection of anti-
body to S-LPS that is immunodominant in the serological
responses of both infected and vaccinated animals.
Below, we describe the main genes involved in LPS bio-
synthesis and the role of their encoding products.
Perosamine synthetase(per)
Godfroid et al. [30] described molecular analysis of the
genes required for the synthesis of the O-antigen of Bru-
cella melitensis 16 M. The perosamine synthetase gene was
cloned and sequenced. In V. cholerae O1, perosamine is
synthesized from fructose 6-phosphate via four interme-
diates: mannose 6-phosphate, mannose 1-phosphate,
GDP-mannose, and 4-keto-6-dideoxymannose. Ulti-
mately, this final product is converted to GDP-pero-
samine by the perosamine synthetase [31]. Because the
last step of the perosamine synthesis pathway is identical
for V. cholerae and B. melitensis, it was assumed that the
earlier steps might be similar or identical for these two
organisms. In Brucella, the GDP-perosamine would then
serve as a substrate for the addition of a formyl group and
could then be polymerized into the O-antigen, translo-
cated to the periplasm, transferred to the lipid A-core oli-
gosaccharide, and exported to the cell surface. The
disruption of per (B3B2 mutant) totally disabled the O-
side chain biosynthesis of B. melitensis 16 M. The muta-
tion was recreated by gene replacement, indicating that
the mutant phenotype was due to the transposon inser-
tion rather than to spontaneous mutation [30]. Indeed,
such a disruption prevented any O-side chain production,
not only at the surface but also in the cytoplasm of the
bacteria indicating that the mutation does not affect the
transport of the O-side chain to the outer membrane but
does affect an earlier stage of biosynthesis.
Phosphomannomutase (pmm or manB)
Allen et al. [27] to better characterize the role of O-antigen
in virulence and survival used transposon mutagenesis to
generate B. abortus rough mutants defective in O-antigen
presentation. A mutant strain was characterized by a trun-
cated rough LPS and DNA sequence analysis of this
mutant revealed a transposon interruption in the gene
encoding phosphomannomutase (pmm  or  manB), sug-
gesting that this activity may be required for the synthesis
of a full-length core polysaccharide in addition to O-anti-
gen. This gene is responsible for the interconversion of
mannose-6-phosphate and mannose-1-phosphate. In
Brucella, mannose is both an important precursor in the
O-antigen biosynthetic pathway and in the production of
the inner core moiety of LPS [32].
Mannosyltransferases (wbkA, WbdA, B and C)
B. abortus genes involved in chronic infection were identi-
fied by assessing the ability of 178 signature-tagged
mutants to establish and maintain persistent infection in
mice [33]. Each mutant was screened for its ability to col-
onize the spleens of mice at 2 and 8 weeks after inocula-
tion. A mutant with defects in establishing chronic
infection which carried a transposon insertion in a B. abor-
tus homologue of Brucella melitensis wbkA, encoding a N-
formyl-perosaminyltransferase that functions in the bio-
synthesis of O-antigen, was the most highly attenuated. In
E. coli O9a polysaccharide is polymerised by the action of
three different mannosyltransferases WbdA, B and C [34].
In this scheme, WbdC transfers a mannose to the endog-
enous acceptor (GlcNAc-pyrophosphoundecaprenol).
This reaction initiates the growth of the polysaccharide
chain and provides the acceptor for subsequent progres-
sive chain elongation by the sequential activities of WbdB,
transferring successive mannosyl units into the 3 position,
and of WbdA, transferring successive mannosyl units at
the 2 position of the previous mannose. On the basis of
this scheme, the presence of α-1,2 and α-1,3 linkages in
the LPS O-side-chain of Brucella suggests the existence of
at least two N-formyl-perosaminyltransferases, WbkA and
WboA. The WbkA could interact with WboA to elongate
the Brucella LPS O-side-chain by α-1,2 and α-1,3 links.
The  wboA  gene that encodes a glycosyltransferase, an
enzyme also essential for the biosynthesis of the O-side
chain in B. abortus was characterized by McQuiston et al.
[35]. The disruption of the wboA gene in smooth strains B.
abortus  2308,  B. melitensis 16 M and B. suis biovar 4
resulted in conversion to a rough phenotype and attenu-
ated [28]. Vemulapalli et al. [36] discovered that the wboA
gene is interrupted by an IS711 element in B abortus vac-
cine strain RB51. The complementation of RB51 with a
functional wboA gene resulted in O-antigen production
but did not result in reversion to the smooth phenotype
and did not affect attenuation, suggesting that RB51 con-
tains an additional genetic mutation(s) that probably
affects either the export of O-antigen to the bacterial sur-
face, the coupling of O-antigen to core lipopolysaccha-
ride, or both [37]. Two rough mutant strains RA1 and
VTRM1 derived from virulent B. abortus 2308 or B.
melitensis  16 M, respectively have identical mutations
wboA gene. RA1 strain was more sensitive to the bacteri-
cidal action of nonimmune human serum and more com-Microbial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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plement components were deposited on its surface than
on strain VTRM1 [38]. Similar species-specific differences
in both complement deposition and complement-medi-
ated killing were also observed when strain RA1 was com-
pared with another rough mutant of B. melitensis, WRR51.
Strain WRR51 was derived from B. melitensis strain 16 M
by replacement of the internal region of the wboA gene
with an antibiotic resistance cassette instead of having a
transposon insertion on this gene, as in the case of VTRM1
or RA1. There were no significant differences in either
complement deposition or killing between VTRM1 and
WRR51 [39]. Both strains were less susceptible than RA1
to the deposition of complement and complement-medi-
ated killing. The LPS of strains RA1 and RB51 with the LPS
of strain 2308 were compared and silver staining indi-
cated that no O-side chain was associated with LPS of
strains RA1 or RB51, and compositional analysis of
smooth and rough B. abortus LPS revealed that 2-keto-3-
deoxy-D-manno-2-octulosonic acid (KDO) was the pre-
dominant glycose in the rough LPS [35]. Vizcaíno et al.
[40] studying DNA polymorphism in the omp25/omp31
family of Brucella spp., identified a 15.1 kb fragment
absent in Brucella ovis. The region absent from B. ovis sug-
gests that this DNA fragment is a genomic island acquired
by the Brucella ancestor by horizontal transfer and later
deleted from B. ovis. This deletion includes wboA and two
other genes that might be involved in the LPS synthesis.
Absence of these genes in B. ovis may explain, at least in
part, the rough phenotype naturally displayed by this Bru-
cella species. The complementation of rough B. ovis PA
with plasmids bearing wboA, bearing wboA and the down-
stream gene potentially encoding a mannosyltransferase
or bearing almost the entire 15.1 kb DNA fragment
deleted in B. ovis strains did not confer a smooth pheno-
type, as shown by the lack of reactivity with a MAb specific
for the Brucella spp S-LPS. This finding suggests that other
genes required for the synthesis of S-LPS located at other
chromosomal loci are affected in B. ovis. It seems clear that
removal of the 15.1 kb genomic island from the smooth
Brucella strains would reduce their virulence, since it was
shown that the Tn5-disruption of wboA reduces survival of
B. abortus in mice [35]. It would be interesting to deter-
mine how the complementation of B. ovis with the deleted
genomic island would affect the virulence of this Brucella
species.
Phosphoglucomutase (pgm)
The gene encoding for phosphoglucomutase (pgm) is
involved in O-antigen biosynthesis in B. abortus [41]. This
gene is absolutely necessary for the biosynthesis of ADP-
glucose, UDP-glucose, and UDP-galactose, the donors of
glucose or galactose for the biosynthesis of molecules con-
taining these sugars. The predicted protein is 74.7% iden-
tical to its homologue in Agrobacterium tumefaciens but is
not part of the glycogen operon as it is in Agrobacterium. B.
abortus LPS O-antigen is a homopolymer of perosamine, a
derivative of mannose that is synthesized through GDP-
mannose, thus, a pgm mutant of this species would not be
impaired in the synthesis of GDP-perosamine, the sugar
donor of O-antigen subunits. Insertional mutagenesis of
pgm  was carried out introducing a gentamicin-resistant
gene within the B. abortus pgm gene and the electro-
phoretic profile of the LPS extracted from this mutant
strain indicated lack of the O-antigen. This mutant was
unable to survive in mice but replicates in HeLa cells, indi-
cating that the complete LPS is not essential either for
invasion or for intracellular multiplication. This behavior
suggests that the LPS may play a role in extracellular sur-
vival in the animal, probably protecting the bacteria
against complement-mediated lysis, but is not involved in
intracellular survival. The fact that the mutant replicates at
a lower rate is not necessarily a consequence of the rough
phenotype, since the absence of pgm affects many other
components of the cell wall, such as, for example, the syn-
thesis of β (1,2) cyclic glucan [42]. Sequence analysis of
the regions upstream and downstream of Brucella pgm
revealed no significant homology to any gene in the data-
base, which was surprising since in A. tumefaciens and
Rhizobium loti, pmg is part of the glycogen operon.
ABC type transporters (Wzm and Wzt)
Godfroid et al. [43] identified, sequenced and character-
ized a chromosomal locus of a 14-kb, wbk biosynthesis
gene cluster, involved in the LPS O-side-chain biosynthe-
sis of B. melitensis 16 M. Analysis of the nucleotide
sequence revealed the presence of seven open reading
frames (ORFs), with six of them showing homology with
genes involved in LPS O-side-chain biosynthesis from
other organisms, and surrounded by four entire and one
partial insertion sequences (IS). The seven ORFs were
named according to the bacterial polysaccharide gene
nomenclature proposed by Reeves et al. [44]. The GCG
Gap program (Wisconsin package version 9.1, Genetic
Computer Group, Madison, WI) was used to compare the
deduced gene products and their similarity to various pro-
tein homologues. Seven genes of the wbk locus of Brucella
melitensis 16 M were wbkA, gmd, per, wzm, wzt, wbkB, and
wbkC, coding, respectively, for proteins homologous to N-
formyl-perosaminyltransferase, GDP-mannose 4,6 dehy-
dratase, perosamine synthetase, ABC-type transporter
(integral membrane protein), ABC-type transporter
(ATPase domain), a hypothetical protein of unknown
function, and a putative formyl transferase [45]. The wzm
and wzt (putative the integral membrane component of
ABC transporters) mutation resulted in a rough pheno-
type of B. melitensis 16 M colonies as shown by crystal vio-
let colony staining [43]. The wzm/wzt mutant also failed to
react in ELISA on whole cells with MAbs directed against
the S-LPS O-side-chain of Brucella  species (anti-S-LPS
MAbs), confirming the absence of the O-side-chain on theMicrobial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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bacterial surface. Three complete and one incomplete
insertion sequences in close association with the wbk gene
cluster were found (ISBm1, ISBm, ISBm3, ISBm4). The
presence of several ISs in intimate association with the
wbk locus is intriguing. Since IS elements are suggested to
play an important evolutionary role in mediating chro-
mosomal rearrangements, it seems likely that they might
have contributed to the structural evolution and probably
horizontal acquisition of the O-antigen biosynthesis gene
cluster in Brucella spp.
Mannose (manA, B, C)
Monreal et al. [46] showed that several LPS genes flank the
seven genes described by Godfroid et al.[43]. These genes
include  manA,  manB, and manC, and their position
strongly suggests that they act coordinately with gmd and
per  and independently of other mannose genes. Poly-
myxin B sensitive mutants were isolated by transposon
mutagenesis of B. abortus 2308 and screening for viability
loss after a controlled exposure to an excess of this antibi-
otic [47]. Since the O-polysaccharide plays a role in pro-
tection against polymyxin B, these mutants were further
screened for O-polysaccharide defects by agglutination
with anti-S-LPS antibodies. Four mutants negative in this
test were then chosen on the basis of their different poly-
myxin B sensitivities. Computer database analysis
revealed that the mini-Tn5 was inserted in the per gene,
wbkA, manB and open reading frame provisionally named
wa**. This gene product was a membrane protein of the
glycosyltransferase family involved in LPS biosynthesis,
but it was different from other putative glycosyltrans-
ferases described before as involved in LPS synthesis in
Brucella. Monreal et al. [46] did a search in the complete
genome sequence of B. melitensis 16 M and B. suis 1330
and revealed a single homologous genes for per and wbkA,
both located in the wbk region. The gene homologous to
wa** was also in chromosome I, although in a different
region. On the other hand, the B. melitensis and B. suis
manB homologues were in chromosome II, along with a
manC gene putatively coding for both mannose-6-P-iso-
merase and mannose-1-P-guanylyltransferase activities.
Since phenotypic analysis revealed a severe core defect in
the mutant, the gene was designated manBcore. The genes
wa** and manBcore are involved in the biosynthesis of the
B. abortus LPS core. In contrast to the parental strain, per,
wbkA, wa**, and manBcore mutants were resistant to the S-
Brucella-specific phages and sensitive to the R-Brucella-spe-
cific phage R/C. Moreover, it was observed that the man-
Bcore mutant showed the lowest R/C phage sensitivity and
the highest polymyxin B resistance and that, conversely,
the wa** mutant had the highest R/C phage sensitivity
and the lowest polymyxin B resistance.
Besides the antigen-O, the lipid A is the part of the LPS
molecule responsible for its endotoxic activity. In B.
melitensis 16 M (Table 2) and B. suis (Table 3) were already
identified some genes involved in lipid A biosynthesis,
however mutants for those genes have not been described
what makes harder to define the role of these gene prod-
ucts in LPS synthesis.
Interaction between Brucella LPS and host 
innate immunity
In contrast to other intracellular pathogens, Brucella spe-
cies do not produce exotoxins, antiphagocytic capsules or
thick cell walls, resistant forms or fimbriae and do not
show antigenic variation [48]. A key aspect of the viru-
lence of Brucella is its ability to proliferate within profes-
sional and non-professional phagocytic host cells.
Therefore, Brucella successfully bypasses the bactericidal
effects of phagocytes, and their virulence and chronic
infections are thought to be due to their ability to avoid
the killing mechanisms of host cells [49]. Some studies
with non-professional phagocytes have shown that Bru-
cella invades host cells and is contained within early endo-
some-like vacuoles. These vacuoles rapidly fuse with early
autophagosomes that acquire vacuolar H+-ATPase and
lysosome-associated membrane proteins (LAMP) matur-
ing into a late autophagosome. These autophagosomes
inhibit fusion with lysosomes and finally become a repli-
cating vacuole normally associated with the endoplasmic
reticulum [50,51]. Porte et al. showed that the LPS O-side
chain is involved in inhibition of the early fusion between
Brucella suis containing phagosomes and lysosomes in
Table 2: Genes encoding lipid A biosynthesis in Brucella melitensis16 M.
Gene Product Location/Chromosome I/II
LpxA Acyl-(acyl carrier protein) UDP-N-acetylglucosamine-O acyltransferase 856881 – 857729/I
LpxC UDP-3-O-(3Hydroxymyristoyl) N-acetylglucosamine diacetylase 608267 – 609127/I
LpxD UDP-3-O-(3Hydroxymyristoyl) glucosamine N-acetyltransferase 855363 – 856418/I
LpxB Lipid-A-disaccharide synthetase 858609 – 859796/I
LpxK Tetraacyldisaccharide-1-P4'-Kinase 1067291 – 1068316/II
KdsA 2-dehydro-3-deoxyphosphooctonate aldolase 876651 – 877448/I
KdsB 3-deoxy-manno octulosanate cytidylyl transferase 1959311 – 19601981/I
KdtA 3-deoxy-D-manno octulosonic-acid transferase 1068319 – 1069659/II
HtrB Lauroyl/myristoyl acyltransferase 1159853 – 1160776/IMicrobial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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murine macrophages at least during the first few hours
after phagocytosis [52]. In contrast, the phagosomes con-
taining rough mutants, which fail to express the O-anti-
gen, rapidly fuse with lysosomes. The LPS O-chain might
be a major factor that governs the early behavior of bacte-
ria inside macrophages.
Recognition of the presence of LPS by cells such as mono-
cytes and macrophages has evolved over centuries to pro-
vide the mammalian host with a rapid recognition of and
reaction towards Gram-negative infection. This rapid,
innate response against LPS typically involves the release
of a range of pro-inflammatory mediators, such as TNF-α,
IL-6, IL-12 and IL-1β, which in local sites of infection and
in moderate levels benefit the host greatly by promoting
inflammation and otherwise priming the immune system
to eliminate the invading organisms. However, in condi-
tions where the body is exposed to LPS excessively or sys-
temically (as when LPS enters the blood stream), a
systemic inflammatory reaction can occur, leading to mul-
tiple organ failure, shock and potentially death [53].
Recognition of bacterial LPS is mediated by CD14, how-
ever, CD14 lacks transmembrane and intracellular
domains necessary for signal transduction and thus
requires the involvement of molecules belonging to the
TLR family. The recent discovery of TLR proteins, a family
of mammalian pattern recognition receptors, has pro-
vided new insights into our understanding of the mecha-
nisms by which Brucella can elicit cellular responses from
innate immune cells. B. abortus induces interleukin (IL)-
12 production from human monocytes and this effect was
blocked by anti-CD14 antibody, suggesting that the Bru-
cella binding and/or signaling to monocytes was mediated
via LPS [54]. Additionally, Brucella's ability to elicit IL-12
secretion enables it to drive Th0 cells to differentiate into
Th1 effector and memory cells that are a central feature of
the potential use of B. abortus as a vaccine carrier and adju-
vant.
Our group has investigated the ability of B. abortus and its
purified LPS and lipid A to trigger TLR2 and TLR4 and the
impact of this activation in innate recognition and elimi-
nation of invading bacteria [55]. CHO reporter cell lines
transfected with CD14 and TLRs showed that B. abortus
triggers both TLR2 and TLR4. In contrast, lipopolysaccha-
ride (LPS) and lipid A derived from Brucella rough (R) and
smooth (S) strains activate CHO cells only through TLR4.
Consistently, macrophages from C3H/HePas mice
exposed to R and S strains and their LPS produced higher
levels of tumor necrosis factor alpha (TNF-α) and inter-
leukin-12 compared to C3H/HeJ, a TLR4 mutant mouse.
The essential role of TLR4 for induction of proinflamma-
tory cytokines was confirmed with diphosphoryl lipid A
from Rhodobacter sphaeroides. Furthermore, to determine
the contribution of TLR2 and TLR4 in bacterial clearance,
numbers of Brucella were monitored in the spleen of C3H/
HeJ, C3H/HePas, TLR2 knockout, and wild-type mice at 1,
3, and 6 weeks following B. abortus infection. Interest-
ingly, murine brucellosis was markedly exacerbated at
weeks 3 and 6 after infection in animals that lacked func-
tional TLR4 (C3H/HeJ) compared to C3H/HePas that par-
alleled the reduced gamma interferon production by this
mouse strain. By mass spectrometry analysis we found
dramatic differences on the lipid A profiles of R and S Bru-
cella strains when compared to E. coli lipid A (Figure 2). As
shown in Figure 2, Brucella rough and smooth lipid A pos-
sess more heptaacylated species than E. coli lipid A that
presents more hexaacylated residues. In conclusion, these
results indicate that TLR4 plays a role in resistance to B.
abortus infection. In contrast, Giambartolomei et al [56]
claimed that lipoproteins Omp19 and Omp16 signaling
through TLR2 rather than LPS are the key molecules
involved in the proinflammatory response mediated by
IL-6 and TNF-α observed during Brucella infection. This
phenomenon seems to be related to the lipid moiety of
the proteins. Therefore, TLR2 and TLR4 signaling during
Brucella infection are mediated by two different ligands,
lipoproteins and LPS, respectively. More recently, Weiss et
al. [57] found that during infection of macrophages, Bru-
cella avoids activation of TLR4 at six hours but activates
TLR4, TLR2, and MyD88 (myeloid differentiation factor
88) at 24 hours postinfection. Interestingly, even though
its activation is delayed, among the three MyD88 is the
Table 3: Genes encoding lipid A biosynthesis in Brucella suis.
Gene Product Location/Chromosome I/II
LpxA Acyl-(acyl carrier protein) UDP-N-acetylglucosamine-O acyltransferase 1130902 – 1131738/I
LpxC UDP-3-O-Acyl-N-acetylglucosamine diacetylase 1379039 – 1379899/I
LpxD UDP-3-O-(3Hydroxymyristoyl) glucosamine N-acetyltransferase 1132213 – 1133268/I
LpxB Lipid-A-disaccharide synthetase 1128835 – 1130022/I
LpxK Tetraacyldisaccharide-1-P4'-Kinase 202326 – 203351/II
KdsA 2-dehydro-3-deoxyphosphooctonate aldolase 1111145 – 1111978/I
KdsB 3-deoxy-manno octulosanate cytidylyl transferase 43162 – 43917/I
KdtA 3-deoxy-D-manno octulosonic-acid transferase 200983 – 202323/II
HtrB Lauroyl acyltransferase 824862 – 825788/IMicrobial Cell Factories 2006, 5:13 http://www.microbialcellfactories.com/content/5/1/13
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most important molecule for host defense against Brucella
infection in vivo, since MyD88 knockout (KO) mice are
more susceptible to infection when compared to TLR4,
TLR2, TLR4/TLR2 KO mice. These findings open the pos-
sibility for the involvement of other TLRs that signal
through MyD88 in host resistance against Brucella infec-
tion. As a matter of fact, Huang et al. [58] demonstrated
that HKBA (heat-killed Brucella abortus) stimulates den-
dritic cells (DC) via TLR9 to secrete IL-12. Furthermore,
this effect can be stimulated by DNA derived from HKBA
and can be blocked by addition of suppressive oligodeox-
ynucleotides (ODNs). The consequence of TLR9 engage-
ment is that Th1-like responses such as IFN-g production
takes place in wild-type but not TLR9 KO mice.
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